Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Have you ever imagined turning a simple sketch into a fully detailed 3D model without the usual headaches of trial and error? Enter Nano Banana, a tool so unexpected in its origins, yet so innovative ...

Princeton Day School finished with the best winning percentage of any team in the Colonial Valley Conference Valley Division a year ago at 13-10, yet finished behind 13-win leaders Steinert and ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

Management described seeking an amendment to the VERSATILE-003 protocol to elevate progression-free survival (PFS) as a surrogate primary endpoint, in addition to maintaining median overall survival ...

OpenAI on Tuesday said it had completed its recapitalization, splitting the AI lab into a for-profit corporation nested inside a non-profit foundation. It’s the end result of a complex legal process ...

The artificial intelligence company said the nonprofit that controlled the organization would receive a $130 billion stake in the new company. The artificial intelligence company said the nonprofit ...

PRINCETON, N.J., Sept. 18, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the ...

Kendall Jenner is building her empire—literally. While the Kardashians star has found success in the modeling world, she admitted there’s one line of work she’d put her runway career on hold for. “I ...

The debate about AI’s impact on consulting tends to swing between two extremes: Some argue that AI will render consultants obsolete; others claim it will only make them more indispensable. Both views ...